Drug Patent Expirations in April 2012

Drug Patent Expirations in April 2012

*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
BROVANA Sunovion arformoterol tartrate 6,068,833 Apr 3, 2012
BROVANA Sunovion arformoterol tartrate 6,866,839 Apr 3, 2012
BROVANA Sunovion arformoterol tartrate 6,589,508 Apr 3, 2012
BROVANA Sunovion arformoterol tartrate 5,795,564 Apr 3, 2012
ALTACE King Pfizer ramipril 5,403,856 Apr 4, 2012
TRITEC Glaxosmithkline ranitidine bismuth citrate 5,403,830 Apr 4, 2012
ALTACE King Pharms ramipril 5,403,856 Apr 4, 2012
TRITEC Glaxosmithkline ranitidine bismuth citrate 5,407,688 Apr 4, 2012
MULTIHANCE Bracco gadobenate dimeglumine 4,916,246 Apr 10, 2012
MULTIHANCE MULTIPACK Bracco gadobenate dimeglumine 4,916,246 Apr 10, 2012
LESCOL Novartis fluvastatin sodium 5,354,772*PED Apr 11, 2012
COMBIVENT RESPIMAT Boehringer Ingelheim albuterol sulfate; ipratropium bromide 5,405,084 Apr 11, 2012
LESCOL XL Novartis fluvastatin sodium 5,354,772*PED Apr 11, 2012
TARGRETIN Eisai Inc bexarotene 6,320,074 Apr 22, 2012
TARGRETIN Eisai Inc bexarotene 7,655,699 Apr 22, 2012
TARGRETIN Eisai Inc bexarotene 6,043,279 Apr 22, 2012
OPTISON Ge Healthcare albumin human 5,573,751 Apr 25, 2012
NAVSTEL Alcon Pharms Ltd calcium chloride; dextrose; magnesium chloride; oxiglutatione; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate 5,409,904 Apr 25, 2012
NAVSTEL Alcon Pharms Ltd calcium chloride; dextrose; magnesium chloride; oxiglutatione; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate 5,578,578 Apr 25, 2012

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin. Courtesy of DrugPatentWatch.com


Leave a Reply